Pars Plana Vitrectomy and Influence of Perfluorocarbon Liquids on Retinal Displacement

NCT ID: NCT07027098

Last Updated: 2025-06-18

Basic Information

• Recruitment Status: NOT_YET_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 292 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-07-01
• Study Completion Date: 2027-10-01

Brief Summary

Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, with an incidence of approximately 10 per 100,000 people. Surgical interventions for treating RRD include pars plana vitrectomy (PPV), which currently represents the main adopted surgical choice. Main outcomes of successful RRD surgery have mainly been represented by anatomical retinal reattachment and best-corrected visual acuity (BCVA). Despite successful surgery, patients with mac-off RRD often report postoperative visual complaints of distortion such as metamorphopsia and scotomas in their central visual field, with great variability.

Major advances in retinal imaging including wide-field optical coherence tomography (OCT) and fundus autofluorescence (FAF) allowed to investigate morphological changes after RRD surgery. The concept of retinal displacement - where the retina has reattached but the exact location has shifted, as evidenced by retinal vessel printing shown on post operative retinal imaging.

Postoperative retinal displacement has been observed to occur with different frequency in relationship to variables including postoperative tamponade, surgical technique, and intraoperative use of perfluorocarbon liquids (PFCL). The investigators hope to formally study the impact of intraoperative use of PFCL, which is used as an aid during surgery to help flatten and position the retina, on retinal displacement. This will help us better understand the impact of this tool on outcomes both objectively through retinal imaging, and subjectively through visual outcomes including visual acuity and measures of distortion and other visual disturbances.

Detailed Description

Rhegmatogenous retinal detachment (RRD) is an acute, sight threatening condition, resulting from the separation of the neurosensory retina from the underlying retinal pigment epithelium (RPE). It is caused by at least one retinal break and recruitment of intraocular fluid into the subretinal space. Surgical interventions for treating RRD include pars plana vitrectomy (PPV), which currently represents the most widely adopted surgical choice, scleral buckling (SB) and pneumatic retinopexy (PnR).

Significant visual loss is the main complaint of patients with macula-involving RRD (MIRD). Hence, the main outcomes of successful RRD surgery have historically been represented by postoperative anatomical retinal reattachment and best-corrected visual acuity (BCVA). However, despite successful surgery, patients with MIRD often report postoperative visual complaints of distortion such as metamorphopsia, aniseikonia and scotomas in their central visual field, with great variability.

Major advances in retinal imaging contributed to provide a better understanding of postoperative visual complaints after surgery for RRD. In particular, optical coherence tomography (OCT) highlighted drop-out of the ellipsoid zone (EZ) or outer and inner retinal folds in the macula area. However, only more recently, hyperautofluorescent lines, also called Retinal Vessel Printing (RVP), adjacent to the retinal blood vessels, were noted on autofluorescence imaging in patients who underwent RRD surgery. This finding is believed to be secondary to unintentional retinal displacement after RRD surgery and may serve as a surrogate anatomical marker of postoperative metamorphopsia and central scotomas.

Postoperative retinal displacement is potentially influenced by several variables including intraocular tamponade, adopted surgical technique, intraoperative use of perfluorocarbon liquids (PFCL) and postoperative posture. The effect of PFCL on retinal displacement is currently unknown due to lack of RCTs and significant limitations of previous research. Therefore, the aim of this RCT is to investigate the role of intraoperative PFCL on postoperative retinal displacement in patients with MIRD undergoing PPV with immediate postoperative face-down posture.

The investigators aim to evaluate whether intraoperative PFCL affects the incidence and patterns of postoperative retinal displacement. As secondary outcomes, this RCT will also investigate the effect of intraoperative use of PFCL on functional outcomes, e.g. BCVA, metamorphopsia and aniseikonia. All patients participating in the trial will be randomly allocated to having surgery either with or without the use of PFCL, and will be followed up regularly after surgery for up to 6 months.

Conditions

Retinal Displacement After Retinal Detachment Surgery

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Retinal Detachment Surgery (Vitrectomy) With Perflurocarbon liquid use.

Standard retinal detachment surgery (vitrectomy) with the use of Perflurocarbon liquid (PFCL) to stabilise macular during surgery and drainage of subretinal fluid. PFCL is then fully removed before the end of surgery.

Group Type: EXPERIMENTAL

Perflurocarbon liquid

Intervention Type: PROCEDURE

Used to facilitate surgery of retinal detachment to stabilise macular during surgery.

Retinal Detachment Surgery (Vitrectomy) Without Perflurocarbon liquid use.

Standard retinal detachment surgery (vitrectomy) without the use of Perflurocarbon liquid (PFCL).

Group Type: ACTIVE_COMPARATOR

Without Perflurocarbon liquid

Intervention Type: PROCEDURE

Standard retinal detachment surgery (vitrectomy) without the use of Perflurocarbon liquid (PFCL).

Interventions

Perflurocarbon liquid

Used to facilitate surgery of retinal detachment to stabilise macular during surgery.

Intervention Type: PROCEDURE

Without Perflurocarbon liquid

Standard retinal detachment surgery (vitrectomy) without the use of Perflurocarbon liquid (PFCL).

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• 18 years of age, or older.
• Diagnosis of primary MIRD with posterior vitreous detachment, and fovea off (confirmed with OCT)
• Surgeons' decision that the patient is eligible for using gas as postoperative tamponade.
• The surgeon is confident to proceed with surgery with or without the use of intraoperative PFCL

Exclusion Criteria

• Previous RRD and/or RRD surgery in the study eye
• Decision to use adjunct scleral buckle
• Decision to use silicone oil as tamponade
• Retinal detachment with macula on
• Patients with other retinal pathologies causing permanent structural changes to the retina in the study eye, such as diabetic retinopathy (assessed above background, or any diabetic maculopathy), previous vascular occlusion (artery or vein occlusion), macula dystrophy, among others
• Previous vitreoretinal surgery in the study eye
• Inability to come for follow ups up to 3 months
• Inability to take FAF and OCT imaging due to neck stiffness or other medical issue
• Mental incapacity
• Patient is unwilling or unable to follow or comply with all study related procedures or to sign informed consent form.
• Contraindications for PFCL
• Previous enrollment in a clinical trial involving retinal diseases and/or treatments
• Media opacity leading to poor quality retinal images (not including post operative significant cataract. See section 7.11)
• Patient inability to posture following surgery

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Francesco Sabatino

Role: PRINCIPAL_INVESTIGATOR

Norwich University Hospitals NHS Foundation Trust,

Locations

Norwich University Hospitals NHS Foundation Trust

Norwich, Norfolk, United Kingdom

Countries

United Kingdom

Central Contacts

Francesco Sabatino

Role: CONTACT

francesco.sabatino@nnuh.nhs.uk

+441603 286286

Sean Zhou

Role: CONTACT

Sean.Zhou@nnuh.nhs.uk

+441603 286286

Facility Contacts

Julie Dawson

Role: primary

RDOffice@nnuh.nhs.uk

+441603286611

Other Identifiers

327806 (129-06-23)

Identifier Type: -

Identifier Source: org_study_id